FIRST MANHATTAN CO. LLC. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,620
-24.7%
4000.0%0.00%
Q2 2023$12,772
+4.3%
4000.0%0.00%
Q1 2023$12,248
-21.7%
4000.0%0.00%
Q4 2022$15,644
-17.7%
4000.0%0.00%
Q3 2022$19,000
+26.7%
4000.0%0.00%
Q2 2022$15,000
-31.8%
4000.0%0.00%
Q1 2022$22,000
-29.0%
4000.0%0.00%
Q4 2021$31,000
-8.8%
4000.0%0.00%
Q3 2021$34,000
-33.3%
4000.0%0.00%
Q2 2021$51,000
+59.4%
4000.0%0.00%
Q1 2021$32,0000.0%4000.0%0.00%
Q4 2020$32,000
+255.6%
4000.0%0.00%
Q3 2020$9,0004000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders